News
News
Local News
Crime & Public Safety
Your Tax Dollars At Work
Politics
Massachusetts
Nation
World
Business
Health
Weather
Columnists
Traffic
Sports
Sports
Red Sox
Patriots
Celtics
Bruins
College
High School
More Sports
Scores & Stats
Entertainment
Entertainment
Celebrity News
Arts & Culture
Movies
Television
Music
Fun & Games
Horoscope
Lottery
Comics
Puzzles
Lifestyle
Lifestyle
Food & Beverage
Travel
Style & Fashion
Obituaries
Obituaries
Local Obituaries
Submit an Obituary
Opinion
Opinion
Editorials
Op-Ed
Letters
Submit a Letter
Radio
Weather
E-Edition
Subscribe
Sign Up For Newsletters
News
News
Local News
Crime & Public Safety
Your Tax Dollars At Work
Politics
Massachusetts
Nation
World
Business
Health
Weather
Columnists
Traffic
Sports
Sports
Red Sox
Patriots
Celtics
Bruins
College
High School
More Sports
Scores & Stats
Entertainment
Entertainment
Celebrity News
Arts & Culture
Movies
Television
Music
Fun & Games
Horoscope
Lottery
Comics
Puzzles
Lifestyle
Lifestyle
Food & Beverage
Travel
Style & Fashion
Obituaries
Obituaries
Local Obituaries
Submit an Obituary
Opinion
Opinion
Editorials
Op-Ed
Letters
Submit a Letter
Radio
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Articles published by Mainz BioMed NV
< Previous
1
2
Next >
Mainz Biomed Awarded Poster of Distinction at Digestive Disease Week, Positioning the Company for its Planned FDA Trial
May 20, 2024
From
Mainz BioMed NV
Via
GlobeNewswire
Tickers
MYNZ
Mainz Biomed to Present Results of Colorectal Cancer Screening Study eAArly DETECT at Digestive Disease Week 2024 in Washington, D.C.
May 07, 2024
From
Mainz BioMed NV
Via
GlobeNewswire
Tickers
MYNZ
Mainz Biomed Reports Positive Topline Results from Pooled Study Evaluating Novel mRNA Biomarkers and Proprietary AI Algorithm for Integration into Pivotal FDA PMA Clinical Trial for Next Generation Colorectal Cancer Diagnostic
April 25, 2024
From
Mainz BioMed NV
Via
GlobeNewswire
Tickers
MYNZ
Mainz Biomed Reports Full Year 2023 Financial Results
April 09, 2024
From
Mainz BioMed NV
Via
GlobeNewswire
Tickers
MYNZ
Mainz Biomed Organizes HALLO DOC! Event to Highlight Innovations in Colorectal Cancer Treatment
March 19, 2024
From
Mainz BioMed NV
Via
GlobeNewswire
Tickers
MYNZ
Mainz Biomed: Webinar on Early Detection of Colorectal Cancer - Exploring New Laboratory Diagnostic Options
March 18, 2024
From
Mainz BioMed NV
Via
GlobeNewswire
Tickers
MYNZ
Mainz Biomed Presents ColoAlert® at UDH Congress 2024: Leading the Way in Evidence-Based Cancer Screening Innovations
March 12, 2024
From
Mainz BioMed NV
Via
GlobeNewswire
Tickers
MYNZ
Mainz Biomed Partners with Trusted Health Advisors to Support U.S. Go-To-Market Strategy for Next Generation Early Colorectal Cancer Diagnostic
March 05, 2024
From
Mainz BioMed NV
Via
GlobeNewswire
Tickers
MYNZ
Mainz Biomed to Showcase at the Gynecology Conference in Stuttgart, Germany, Strengthening Connections within the Medical Community
February 27, 2024
From
Mainz BioMed NV
Via
GlobeNewswire
Tickers
MYNZ
Mainz Biomed Announces Distribution Partnership with Praxisdienst for ColoAlert®
February 22, 2024
From
Mainz BioMed NV
Via
GlobeNewswire
Tickers
MYNZ
Mainz Biomed Establishes Strategic Partnership with TomaLab to Expand Availability of ColoAlert® in Italy
February 21, 2024
From
Mainz BioMed NV
Via
GlobeNewswire
Tickers
MYNZ
Mainz Biomed Establishes Physician-Led Laboratory Expanding Service Offering for Privately Insured Patients in Germany
February 06, 2024
From
Mainz BioMed NV
Via
GlobeNewswire
Tickers
MYNZ
Mainz Biomed and TestDNA Drive CRC Innovation at the 10th Gdańsk Gastroenterology Symposium
January 11, 2024
From
Mainz BioMed NV
Via
GlobeNewswire
Tickers
MYNZ
Mainz Biomed Provides Year-End Corporate Review 2023
January 09, 2024
From
Mainz BioMed NV
Via
GlobeNewswire
Tickers
MYNZ
Mainz Biomed and Bantleon Partner to Elevate Corporate Health with Second Phase of CRC Screening Program for Employees
December 19, 2023
From
Mainz BioMed NV
Via
GlobeNewswire
Tickers
MYNZ
Mainz Biomed Showcases ColoAlert® at Two Prominent Gastroenterology Conferences in Poland
December 12, 2023
From
Mainz BioMed NV
Via
GlobeNewswire
Tickers
MYNZ
Mainz Biomed Reports Positive Topline Results from U.S. eAArly DETECT Study Evaluating Novel mRNA Biomarkers
December 05, 2023
From
Mainz BioMed NV
Via
GlobeNewswire
Tickers
MYNZ
Mainz Biomed’s Presentation at the 35th Annual Piper Sandler Healthcare Conference to be Made Available via Webcast
November 29, 2023
From
Mainz BioMed NV
Via
GlobeNewswire
Tickers
MYNZ
Mainz Biomed to Present at the 35th Annual Piper Sandler Healthcare Conference
November 20, 2023
From
Mainz BioMed NV
Via
GlobeNewswire
Tickers
MYNZ
Mainz Biomed Reports Third Quarter 2023 Financial Results and Provides Corporate Update
November 16, 2023
From
Mainz BioMed NV
Via
GlobeNewswire
Tickers
MYNZ
Mainz Biomed Announces Closing of $5.0 million Registered Direct Offering
November 15, 2023
From
Mainz BioMed NV
Via
GlobeNewswire
Tickers
MYNZ
Mainz Biomed Announces Pricing of $5.0 million Registered Direct Offering
November 13, 2023
From
Mainz BioMed NV
Via
GlobeNewswire
Tickers
MYNZ
Mainz Biomed Partners with Liquid Biosciences to Harness the Power of Artificial Intelligence (AI) to Develop Next-generation Colorectal Screening Test
November 09, 2023
From
Mainz BioMed NV
Via
GlobeNewswire
Tickers
MYNZ
Mainz Biomed to Showcase ColoAlert® at Leading Global Healthcare Event, MEDICA
November 07, 2023
From
Mainz BioMed NV
Via
GlobeNewswire
Tickers
MYNZ
Mainz Biomed Reports Success from Employee Colorectal Cancer Screening Campaign in Partnership with Zöller-Kipper
October 31, 2023
From
Mainz BioMed NV
Via
GlobeNewswire
Tickers
MYNZ
Mainz Biomed Appoints Tarrin Khairi-Taraki as VP of Commercial Operations
October 26, 2023
From
Mainz BioMed NV
Via
GlobeNewswire
Tickers
MYNZ
Mainz Biomed Presents Groundbreaking Results of ColoFuture Study
October 18, 2023
From
Mainz BioMed NV
Via
GlobeNewswire
Tickers
MYNZ
Mainz Biomed to Showcase ColoAlert® at UEG Week 2023 in Copenhagen, Denmark
October 11, 2023
From
Mainz BioMed NV
Via
GlobeNewswire
Tickers
MYNZ
Mainz Biomed to Attend the JonesTrading 2023 Healthcare Summit
October 05, 2023
From
Mainz BioMed NV
Via
GlobeNewswire
Tickers
MYNZ
Mainz Biomed Announces Live Launch of ColoAlert® with Bioclinica in Romania
October 04, 2023
From
Mainz BioMed NV
Via
GlobeNewswire
Tickers
MYNZ
< Previous
1
2
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.
Close